Would you have concerns starting an anti-TNF in RA patients with history of ITP/chronic idiopathic thrombocytopenia?  

Clinically significant thrombocytopenia is a rare but documented side effect of tumor necrosis factor inhibitors. If an alternate class of medication for this patient can be found, that would be the safest choice. If there is no alternative, then would follow platelets counts frequently.